StockData
Cencora, Inc. logo

Cencora, Inc. (COR) stock

CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 14/3021% above fair value
$348.31−2.25 (-0.64%)

Close on Nov 18, 2026Market cap $66.47BP/E 25.9Yield 0.63%

Cencora gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Cencora's gross profit for the twelve months ending Jun 30, 2026 was $13.22B, up 20.0% year over year. For fiscal 2025 it was $11.48B, up 15.8% from the year before. Over ten years it grew 12.5% a year on average. The highest annual figure on record is $11.48B in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Sep 30, 2025$11.48B+15.8%
FY2024Sep 30, 2024$9.91B+10.6%
FY2023Sep 30, 2023$8.96B+8.0%
FY2022Sep 30, 2022$8.30B+19.5%
FY2021Sep 30, 2021$6.94B+33.7%
FY2020Sep 30, 2020$5.19B+1.0%
FY2019Sep 30, 2019$5.14B+11.4%
FY2018Sep 30, 2018$4.61B+1.5%
FY2017Sep 30, 2017$4.55B+6.4%
FY2016Sep 30, 2016$4.27B+21.1%
FY2015Sep 30, 2015$3.53B+18.3%
FY2014Sep 30, 2014$2.98B+18.9%
FY2013Sep 30, 2013$2.51B-4.8%
FY2012Sep 30, 2012$2.63B+7.1%
FY2011Sep 30, 2011$2.46B+5.8%
FY2010Sep 30, 2010$2.33B+10.7%
FY2009Sep 30, 2009$2.10B+2.6%
FY2008Sep 30, 2008$2.05B-7.8%
FY2007Sep 30, 2007$2.22B–

Quarterly gross profit

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$3.61B+24.1%
Q2 FY2026CQ1 2026Mar 31, 2026$3.59B+17.3%
Q1 FY2026CQ4 2025Dec 31, 2025$3.07B+20.1%
Q4 FY2025CQ3 2025Sep 30, 2025$2.95B+18.5%
Q3 FY2025CQ2 2025Jun 30, 2025$2.91B+20.6%
Q2 FY2025CQ1 2025Mar 31, 2025$3.06B+20.6%
Q1 FY2025CQ4 2024Dec 31, 2024$2.56B+3.6%
Q4 FY2024CQ3 2024Sep 30, 2024$2.49B+10.6%
Q3 FY2024CQ2 2024Jun 30, 2024$2.41B+6.5%
Q2 FY2024CQ1 2024Mar 31, 2024$2.54B+10.6%
Q1 FY2024CQ4 2023Dec 31, 2023$2.47B+15.0%
Q4 FY2023CQ3 2023Sep 30, 2023$2.25B+13.5%
Q3 FY2023CQ2 2023Jun 30, 2023$2.26B+12.4%
Q2 FY2023CQ1 2023Mar 31, 2023$2.30B+2.7%
Q1 FY2023CQ4 2022Dec 31, 2022$2.15B+4.2%
Q4 FY2022CQ3 2022Sep 30, 2022$1.99B-4.1%
Q3 FY2022CQ2 2022Jun 30, 2022$2.02B+6.7%
Q2 FY2022CQ1 2022Mar 31, 2022$2.24B+45.8%
Q1 FY2022CQ4 2021Dec 31, 2021$2.06B+41.9%
Q4 FY2021CQ3 2021Sep 30, 2021$2.07B+53.6%
Q3 FY2021CQ2 2021Jun 30, 2021$1.89B+54.0%
Q2 FY2021CQ1 2021Mar 31, 2021$1.53B+10.5%
Q1 FY2021CQ4 2020Dec 31, 2020$1.45B+18.0%
Q4 FY2020CQ3 2020Sep 30, 2020$1.35B+13.7%
Q3 FY2020CQ2 2020Jun 30, 2020$1.23B-0.4%
Q2 FY2020CQ1 2020Mar 31, 2020$1.39B-2.6%
Q1 FY2020CQ4 2019Dec 31, 2019$1.23B-5.1%
Q4 FY2019CQ3 2019Sep 30, 2019$1.18B+14.7%
Q3 FY2019CQ2 2019Jun 30, 2019$1.23B+1.6%
Q2 FY2019CQ1 2019Mar 31, 2019$1.42B+13.5%
Q1 FY2019CQ4 2018Dec 31, 2018$1.30B+16.6%
Q4 FY2018CQ3 2018Sep 30, 2018$1.03B-11.9%
Q3 FY2018CQ2 2018Jun 30, 2018$1.21B+12.2%
Q2 FY2018CQ1 2018Mar 31, 2018$1.26B-0.1%
Q1 FY2018CQ4 2017Dec 31, 2017$1.11B+7.2%
Q4 FY2017CQ3 2017Sep 30, 2017$1.17B+4.2%
Q3 FY2017CQ2 2017Jun 30, 2017$1.08B–
Q2 FY2017CQ1 2017Mar 31, 2017$1.26B–
Q1 FY2017CQ4 2016Dec 31, 2016$1.04B–
Q4 FY2016CQ3 2016Sep 30, 2016$1.12B–

More Cencora figures

See a number that looks wrong?